论文信息 - Whole genome sequencing of a sporadic primary immunodeficiency cohort

Whole genome sequencing of a sporadic primary immunodeficiency cohort

Primary immunodeficiency (PID) is characterized by recurrent and often life-threatening infections, autoimmunity and cancer, and it poses major diagnostic and therapeutic challenges. Although the most severe forms of PID are identified in early childhood, most patients present in adulthood, typically with no apparent family history and a variable clinical phenotype of widespread immune dysregulation: about 25% of patients have autoimmune disease, allergy is prevalent and up to 10% develop lymphoid malignancies 1 – 3 . Consequently, in sporadic (or non-familial) PID genetic diagnosis is difficult and the role of genetics is not well defined. Here we address these challenges by performing whole-genome sequencing in a large PID cohort of 1,318 participants. An analysis of the coding regions of the genome in 886 index cases of PID found that disease-causing mutations in known genes that are implicated in monogenic PID occurred in 10.3% of these patients, and a Bayesian approach (BeviMed 4 ) identified multiple new candidate PID-associated genes, including IVNS1ABP . We also examined the noncoding genome, and found deletions in regulatory regions that contribute to disease causation. In addition, we used a genome-wide association study to identify loci that are associated with PID, and found evidence for the colocalization of—and interplay between—novel high-penetrance monogenic variants and common variants (at the PTPN2 and SOCS1 loci). This begins to explain the contribution of common variants to the variable penetrance and phenotypic complexity that are observed in PID. Thus, using a cohort-based whole-genome-sequencing approach in the diagnosis of PID can increase diagnostic yield and further our understanding of the key pathways that influence immune responsiveness in humans. Whole-genome sequencing analysis of individuals with primary immunodeficiency identifies new candidate disease-associated genes and shows how the interplay between genetic variants can explain the variable penetrance and complexity of the disease.

[1] M. Tremblay,et al. TC-PTP-deficient bone marrow stromal cells fail to support normal B lymphopoiesis due to abnormal secretion of interferon-{gamma}. , 2007, Blood.

[2] Smita Y. Patel,et al. The United Kingdom Primary Immune Deficiency (UKPID) Registry: report of the first 4 years' activity 2008–2012 , 2014, Clinical and experimental immunology.

[3] C. Cunningham-Rundles,et al. Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations. , 2018, The Journal of allergy and clinical immunology.

[4] J. Casanova,et al. Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype. , 2016, Blood.

[5] A. Fischer,et al. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis , 2011, The Journal of experimental medicine.

[6] Buhm Han,et al. Imputing Amino Acid Polymorphisms in Human Leukocyte Antigens , 2013, PloS one.

[7] Takafumi Yoshida,et al. SOCS1 Is a Suppressor of Liver Fibrosis and Hepatitis-induced Carcinogenesis , 2004, The Journal of experimental medicine.

[8] R. Young,et al. Super-Enhancers in the Control of Cell Identity and Disease , 2013, Cell.

[9] J. Casanova. Human genetic basis of interindividual variability in the course of infection , 2015, Proceedings of the National Academy of Sciences.

[10] B. Berger,et al. Efficient Bayesian mixed model analysis increases association power in large cohorts , 2014, Nature Genetics.

[11] Christian Gieger,et al. Association of CLEC16A with human common variable immunodeficiency disorder and role in murine B cells , 2015, Nature Communications.

[12] D. Valle,et al. GeneMatcher: A Matching Tool for Connecting Investigators with an Interest in the Same Gene , 2015, Human mutation.

[13] Bale,et al. Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[14] G. McVean,et al. Differential confounding of rare and common variants in spatially structured populations , 2011, Nature Genetics.

[15] Keith W. Muir,et al. Whole-genome sequencing of patients with rare diseases in a national health system , 2020, Nature.

[16] M. Lenardo,et al. Genomics of Immune Diseases and New Therapies. , 2016, Annual review of immunology.

[17] J. Casanova,et al. The 2017 IUIS Phenotypic Classification for Primary Immunodeficiencies , 2017, Journal of Clinical Immunology.

[18] C. Cunningham-Rundles,et al. Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency , 2007, Nature Genetics.

[19] Zhaohui S. Qin,et al. A second generation human haplotype map of over 3.1 million SNPs , 2007, Nature.

[20] A. Hoischen,et al. STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. , 2011, The New England journal of medicine.

[21] Di Yu,et al. PTPN2-deficiency exacerbates T follicular helper cell and B cell responses and promotes the development of autoimmunity. , 2017, Journal of autoimmunity.

[22] John Wagner,et al. Impaired Bone Marrow Microenvironment and Immune Function in T Cell Protein Tyrosine Phosphatase–deficient Mice , 1997, The Journal of experimental medicine.

[23] M. Daly,et al. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies , 2014, Nature Genetics.

[24] R. Ramirez-Solis,et al. Combined immunodeficiency with severe inflammation and allergy caused by ARPC1B deficiency. , 2017, The Journal of allergy and clinical immunology.

[25] M. Hershfield,et al. Deficiency of Adenosine Deaminase 2 Causes Antibody Deficiency , 2016, Journal of Clinical Immunology.

[26] Jonathan M. Cairns,et al. Lineage-Specific Genome Architecture Links Enhancers and Non-coding Disease Variants to Target Gene Promoters , 2016, Cell.

[27] A. Worth,et al. Identifying functional defects in patients with immune dysregulation due to LRBA and CTLA-4 mutations. , 2017, Blood.

[28] Andrew R. Gennery,et al. Identification of Heterozygous Single- and Multi-exon Deletions in IL7R by Whole Exome Sequencing , 2016, Journal of Clinical Immunology.

[29] A. Elefanty,et al. Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[30] Crina Samarghitean,et al. Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans , 2018, The Journal of allergy and clinical immunology.

[31] Davis J. McCarthy,et al. Common genetic variation drives molecular heterogeneity in human iPSCs , 2017, Nature.

[32] William J. Astle,et al. Whole-genome sequencing of rare disease patients in a national healthcare system , 2019, bioRxiv.

[33] Ellen Schofield,et al. Chromosome contacts in activated T cells identify autoimmune disease candidate genes , 2017, Genome Biology.

[34] W. Vainchenker,et al. Mechanisms of WASp-mediated hematologic and immunologic disease. , 2004, Blood.

[35] Hailiang Huang,et al. Fine-mapping inflammatory bowel disease loci to single variant resolution , 2017, Nature.

[36] Dorothy A. Thompson,et al. Comprehensive Rare Variant Analysis via Whole-Genome Sequencing to Determine the Molecular Pathology of Inherited Retinal Disease. , 2017, American journal of human genetics.

[37] N. Hayashi,et al. Suppressor of cytokine signaling-1 ameliorates dextran sulfate sodium-induced colitis in mice. , 2008, International immunology.

[38] K. Roeder,et al. Genomic Control for Association Studies , 1999, Biometrics.

[39] Paul J Hertzog,et al. SOCS1 Is a Critical Inhibitor of Interferon γ Signaling and Prevents the Potentially Fatal Neonatal Actions of this Cytokine , 1999, Cell.

[40] Smita Y. Patel,et al. The United Kingdom Primary Immune Deficiency (UKPID) registry 2012 to 2017 , 2018, Clinical and experimental immunology.

[41] F. Cunningham,et al. The Ensembl Variant Effect Predictor , 2016, Genome Biology.

[42] É. Oksenhendler,et al. Clinical picture and treatment of 2212 patients with common variable immunodeficiency. , 2014, The Journal of allergy and clinical immunology.

[43] H. Daum,et al. Autosomal dominant gain of function STAT1 mutation and severe bronchiectasis. , 2017, Respiratory medicine.

[44] E. Banks,et al. Discovery and statistical genotyping of copy-number variation from whole-exome sequencing depth. , 2012, American journal of human genetics.

[45] A. Schäffer,et al. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans , 2005, Nature Genetics.

[46] Jon Wakefield,et al. Bayes factors for genome‐wide association studies: comparison with P‐values , 2009, Genetic epidemiology.

[47] Sylvia Richardson,et al. A Fast Association Test for Identifying Pathogenic Variants Involved in Rare Diseases , 2017, American journal of human genetics.

[48] Jake K. Byrnes,et al. Bayesian refinement of association signals for 14 loci in 3 common diseases , 2012, Nature Genetics.

[49] N. Warner,et al. Loss of the Arp2/3 complex component ARPC1B causes platelet abnormalities and predisposes to inflammatory disease , 2017, Nature Communications.

[50] J. Casanova,et al. The 2015 IUIS Phenotypic Classification for Primary Immunodeficiencies , 2015, Journal of Clinical Immunology.

[51] James Y. Zou. Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.

[52] A. Schäffer,et al. Haploinsufficiency of the NF-κB1 Subunit p50 in Common Variable Immunodeficiency. , 2015, American journal of human genetics.

[53] Hideo Tanaka,et al. Meta-analysis identifies nine new loci associated with rheumatoid arthritis in the Japanese population , 2012, Nature Genetics.

[54] Buhm Han,et al. Disentangling the Effects of Colocalizing Genomic Annotations to Functionally Prioritize Non-coding Variants within Complex-Trait Loci , 2014, bioRxiv.

[55] Caroline F. Wright,et al. De novo mutations in regulatory elements in neurodevelopmental disorders , 2018, Nature.